LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA
With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development